C. Tikellis et al. , «Developmental expression of ACE2 in the SHR kidney: A role in hypertension?» Kidney Int. , vol. 70, no. 1, pp. 34–41, Jul. 2006.
M. Nishiga, D. W. Wang, Y. Han, D. B. Lewis, and J. C. Wu, «COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives», Nat. Rev. Cardiol. , vol. 17, no. 9, pp. 543–558, Sep. 2020.
M. Barnes, A. E. Heywood, A. Mahimbo, B. Rahman, A. T. Newall, and C. R. Macintyre, «Acute myocardial infarction and influenza: a meta-analysis of case — control studies», Heart , vol. 101, no. 21, pp. 1738–1747, Nov. 2015.
M. Dolhnikoff et al. , «SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome», Lancet Child Adolesc. Heal. , Aug. 2020.
D. Lindner et al. , «Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases», JAMA Cardiol. , Jul. 2020.
M. Dolhnikoff et al. , «SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome», Lancet Child Adolesc. Heal. , Aug. 2020.
G. Li, H. Li, and J. Lu, «No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity», Clin. Res. Cardiol. , Apr. 2020.
L. F. Drager, A. Pio-Abreu, R. D. Lopes, and L. A. Bortolotto, «Is Hypertension a Real Risk Factor for Poor Prognosis in the COVID-19 Pandemic?» Curr. Hypertens. Rep. , vol. 22, no. 6, p. 43, Jun. 2020.
K. Sriram and P. A. Insel, «Dangers of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence», medRxiv , p. 2020.03.25.20043927, Jan. 2020.
H. Kai and M. Kai, «Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors — lessons from available evidence and insights into COVID-19», Hypertens. Res. , Apr. 2020.
Там же.
«Nach Corona-Ausbruch in Baptisten-Gemeinde: Weiterer kirchlicher Infektionsherd», FR.de , 2020. [Online]. Available: https://www.fr.de/frankfurt/frankfurt-am-main-ort28687/frankfurt-corona-coronavirus-infektionen-baptisten-gottesdienst-covid-19-krankenhaus-zr-13773287.html. [Accessed: 31-May-2020].
P. de Candia et al. , «Type 2 Diabetes: How Much of an Autoimmune Disease?» Front. Endocrinol. (Lausanne). , vol. 10, Jul. 2019.
D. T. Graves and R. A. Kayal, «Diabetic complications and dysregulated innate immunity»., Front. Biosci. , vol. 13, pp. 1227–39, Jan. 2008.
«Nach Corona-Ausbruch in Baptisten-Gemeinde: Weiterer kirchlicher Infektionsherd», FR.de , 2020. [Online]. Available: https://www.fr.de/frankfurt/frankfurt-am-main-ort28687/frankfurt-corona-coronavirus-infektionen-baptisten-gottesdienst-covid-19-krankenhaus-zr-13773287.html. [Accessed: 31-May-2020].
J. Lighter et al. , «Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission», Clin. Infect. Dis. , Apr. 2020.
A. Simonnet et al. , «High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation», Obesity , Apr. 2020.
A. B. Docherty et al. , «Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol», medRxiv , p. 2020.04.23.20076042, Jan. 2020.
A. E. Dixon and U. Peters, «The effect of obesity on lung function», Expert Rev. Respir. Med. , vol. 12, no. 9, pp. 755–767, Sep. 2018.
R. A. Watson et al. , «Reduction of total lung capacity in obese men: comparison of total intrathoracic and gas volumes», J. Appl. Physiol. , vol. 108, no. 6, pp. 1605–1612, Jun. 2010.
A. E. Dixon and U. Peters, «The effect of obesity on lung function», Expert Rev. Respir. Med. , vol. 12, no. 9, pp. 755–767, Sep. 2018.
X. Zhang et al. , «Systemic inflammation mediates the detrimental effects of obesity on asthma control», Allergy Asthma Proc. , 2017.
R. Huttunen and J. Syrjänen, «Obesity and the risk and outcome of infection», Int. J. Obes. , vol. 37, no. 3, pp. 333–340, Mar. 2013.
UN Women, «COVID-19: Emerging gender data and why it matters», 2020. [Online]. Available: https://data.unwomen.org/resources/covid-19-emerging-gender-data-and-why-it-matters. [Accessed: 05-Jun-2020].
G. H. 50/50, «COVID-19 sex-disaggregated data tracker», 2020. [Online]. Available: https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/. [Accessed: 18-Aug-2020].
C. Karagiannidis et al. , «Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study», Lancet Respir. Med. , Jul. 2020.
H. Ueyama et al. , «Gender Difference Is Associated With Severity of Coronavirus Disease 2019 Infection: An Insight From a Meta-Analysis», Crit. Care Explor. , vol. 2, no. 6, p. e0148, Jun. 2020.
M. J. Nasiri et al. , «COVID-19 clinical characteristics, and sex-specific risk of mortality: Systematic Review and Meta-analysis», medRxiv , p. 2020.03.24.20042903, Jan. 2020.
C. Karagiannidis et al. , «Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study», Lancet Respir. Med. , Jul. 2020.
Robert Koch Institute, «Coronavirus Disease 2019(COVID-19)Daily Situation Report of the Robert Koch Institute. 01/06/2020 — UPDATED STATUS FOR GERMANY», 2020.
G. H. 50/50, «COVID-19 sex-disaggregated data tracker», 2020. [Online]. Available: https://globalhealth5050.org/covid19/sex-disaggregated-data-tracker/. [Accessed: 18-Aug-2020].
C. Vlassoff, «Gender differences in determinants and consequences of health and illness»., J. Health. Popul. Nutr. , vol. 25, no. 1, pp. 47–61, Mar. 2007.
A. E. Thompson, Y. Anisimowicz, B. Miedema, W. Hogg, W. P. Wodchis, and K. Aubrey-Bassler, «The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study», BMC Fam. Pract. , vol. 17, no. 1, p. 38, Dec. 2016.
S. L. Klein and K. L. Flanagan, «Sex differences in immune responses», Nat. Rev. Immunol. , vol. 16, no. 10, pp. 626–638, Oct. 2016.
J. E. Fa, J. R. Stewart, L. Lloveras, and J. M. Vargas, «Rabbits and hominin survival in Iberia», J. Hum. Evol. , vol. 64, no. 4, pp. 233–241, Apr. 2013.
Читать дальше
Конец ознакомительного отрывка
Купить книгу